Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

✍ Scribed by R. Haas; H. Schmid; U. Hahn; S. Hohaus; H. Goldschmidt; S. Murea; M. Kaufmann; M. Wannenmacher; D. Wallwiener; G. Bastert; W. Hunstein

• Book ID: 117665379
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 898 KB
• Volume: 33
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(97)89008-9